AEON

AEON Biopharma, Inc. AMEX Listed Jul 24, 2023

Healthcare ·Biotechnology ·US · aeonbiopharma.com

$0.92

Mkt Cap $10.8M

52w Low $0.43 47.6% of range 52w High $1.45

50d MA $1.02 200d MA $0.95

P/E (TTM) -0.2x

EV/EBITDA -2.6x

P/B —

Debt/Equity -0.7x

ROE 197.4%

P/FCF -0.6x

RSI (14) —

ATR (14) —

Beta 0.73

50d MA $1.02

200d MA $0.95

Avg Volume 103.5K

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

SIC Code

2834

CIK (SEC)

1837607

Phone

949-354-6499

4040 Macarthur Boulevard · Newport Beach, CA 92614 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 30, 2026	AMC	-0.20	-3.72	-1714.6%	0.99	+21.3%	-0.5%	-0.7%	-9.2%	+2.4%	+3.0%	—
Nov 14, 2025	AMC	-0.43	-0.39	+9.3%	0.90	-1.0%	-3.8%	+10.5%	-2.1%	-12.8%	+1.2%	—
Aug 12, 2025	AMC	—	-0.60	—	0.69	-2.9%	+16.1%	-2.5%	-1.5%	-1.7%	-3.2%	—
May 14, 2025	AMC	-13.67	-0.09	+99.3%	0.50	-6.6%	-1.0%	+1.4%	+1.8%	+0.0%	-4.5%	—
Mar 24, 2025	AMC	-12.95	3.75	+129.0%	0.72	+2.2%	-7.3%	+4.3%	-8.6%	-7.3%	-2.2%	—
Nov 13, 2024	AMC	-11.51	-11.51	+0.0%	49.69	+1.4%	-11.4%	+0.9%	-3.3%	-2.8%	-2.8%	—
Aug 12, 2024	AMC	-13.67	-11.51	+15.8%	71.99	+4.0%	-1.0%	+2.0%	+4.0%	-2.9%	-2.0%	—
May 14, 2024	AMC	-22.30	-20.14	+9.7%	117.36	+0.0%	-3.1%	-5.1%	+2.0%	+11.1%	-2.9%	—
Mar 29, 2024	AMC	-0.40	-0.71	-77.5%	—	—	—	—	—	—	—	—
Jun 30, 2023	AMC	—	-40.37	—	—	—	—	—	—	—	—	—
Mar 31, 2023	AMC	—	-0.80	—	—	—	—	—	—	—	—	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Oct 8	Aegis Capital	Maintains	Buy → Buy	—	$0.94	$0.97	+3.7%	-1.6%	+12.0%	+9.7%	-5.3%	+9.3%
Oct 1	HC Wainwright & Co.	Maintains	Buy → Buy	—	$75.60	$75.60	+0.0%	-2.9%	+10.8%	-1.8%	+9.0%	+24.0%
Aug 14	HC Wainwright & Co.	Maintains	Buy → Buy	—	$71.28	$72.00	+1.0%	+2.0%	+4.0%	-2.9%	-2.0%	-1.0%
Jul 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$79.20	$77.40	-2.3%	-5.5%	+1.9%	+32.1%	+62.9%	+25.4%
May 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$108.00	$114.48	+6.0%	-4.0%	+9.7%	+3.8%	-4.9%	-0.6%
May 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$117.36	$117.36	+0.0%	-3.1%	-5.1%	+2.0%	+11.1%	-2.9%
May 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$122.40	$126.00	+2.9%	-4.1%	-2.5%	+11.3%	-6.2%	+4.2%
Apr 17	HC Wainwright & Co.	Maintains	Buy → Buy	—	$496.08	$493.20	-0.6%	-1.5%	-3.7%	-28.7%	+1.3%	-8.9%

Data updated apr 24, 2026 4:18pm · Source: massive.com